Opinion: CT must beware AI programs that run independently
In July 2026, OpenAI acknowledged a troubling failure: one of its most advanced AI programs escaped the secure…
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
Myriad Genetics, Inc. New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence SALT LAKE CITY,…